EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Phibro Animal Health Corporation (PAHC) had EBITDA of $57.67M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$383.54M
Net Income	$24.02M
Cost of Goods Sold	$257.87M
Gross Profit	$125.67M
Operating Expenses	$338.89M
Operating Income	$44.65M
Non-Operating Income/Expense	$-12.34M
Pre-Tax Income	$32.31M
Normalized Pre-Tax Income	$32.31M
Income after Taxes	$24.02M
Income from Continuous Operations	$24.02M
Consolidated Net Income/Loss	$24.02M
Normalized Income after Taxes	$24.02M
EBIT	$44.65M
EBITDA	$57.67M
Weighted-Average Shares Outstanding (Basic)	40.55M
Weighted-Average Shares Outstanding (Diluted)	41.04M
Earnings per Share (EPS) (Basic)	$0.59
Earnings per Share (EPS) (Diluted)	$0.59
Balance Sheet Financials
Current Assets	$894.07M
Property, Plant, and Equipment	$359.27M
Long-Term Assets	$551.05M
Total Assets	$1.45B
Current Liabilities	$281.87M
Long-Term Debt	$712.68M
Long-Term Liabilities	$801.42M
Total Liabilities	$1.08B
Common Equity	$361.83M
Tangible Shareholders Equity	$270.25M
Shareholders Equity	$361.83M
Common Shares Outstanding	40.56M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$44.86M
Cash Flow from Investing Activities	$-55.00M
Cash Flow from Financial Activities	$-4.95M
Beginning Cash	$68.04M
End Cash	$54.93M
Increase/Decrease in Cash	$-13.11M
Stock-Based Compensation	$1.18M
Common Stock Dividends Paid	$-14.60M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.17
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.66
Debt to Equity Ratio	2.03
Gross Margin	32.77%
Operating Margin	11.64%
EBIT Margin	11.64%
EBITDA Margin	--
Pre-Tax Profit Margin	8.42%
Profit Margin	6.26%
Free Cash Flow	$4.64M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.27
Inventory Turnover	0.48
Receiveable Turnover	1.73
Days Sales in Receivables	51.99
Return on Equity	6.64%
Return on Tangible Equity	8.89%
Return on Assets	1.66%
Return on Investments	2.24%
Book Value Per Share	$8.92
Free Cash Flow per Share	$0.11
Operating Cash Flow per Share	$1.09

Data from Zacks Investment Research, Inc.